
Myovant (MYOV), Pfizer sNDA for Myfembree Accepted by the FDA
Published on September 10, 2021
Myovant's (MYOV) application for the label expansion of Myfembree gets accepted by the FDA for the indication of pain associated with endometriosis.

Myovant's (MYOV) application for the label expansion of Myfembree gets accepted by the FDA for the indication of pain associated with endometriosis.